Back
NeuroBo Pharmaceuticals Vs. Cytokinetics Industry Stock Comparison
Sell
19
NRBO
NeuroBo Pharmaceuticals
Last Price:
2.73
Seasonality Move:
-18.3%
Sell
49
CYTK
Cytokinetics
Last Price:
55.63
Seasonality Move:
12.68%
Sell
19
NeuroBo Pharmaceuticals (NRBO)
is a Sell
Is NeuroBo Pharmaceuticals a Buy, Sell or Hold?
- The current NeuroBo Pharmaceuticals [NRBO] share price is $2.54. The Score for NRBO is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
- NRBO is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
49
Cytokinetics (CYTK)
is a Sell
Is Cytokinetics a Buy, Sell or Hold?
- The current Cytokinetics [CYTK] share price is $52.52. The Score for CYTK is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
- CYTK is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NRBO Stock Price Chart
What is NeuroBo Pharmaceuticals's stock price today?
-
The NeuroBo Pharmaceuticals share price today is $2.54
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NRBO is experiencing selling pressure, which indicates risk of future bearish movement.
CYTK Stock Price Chart
What is Cytokinetics's stock price today?
-
The Cytokinetics share price today is $52.52
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CYTK is experiencing buying pressure, which is a positive indicator for future bullish movement.
NRBO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.13 | Sell |
Relative Strength Index (14 RSI): | 38 | Sell |
Chaikin Money Flow: | -18122 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.56 - 2.88) | Sell |
Bollinger Bands (100): | (2.95 - 4.31) | Sell |
CYTK Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.77 | Sell |
Relative Strength Index (14 RSI): | 47.02 | Sell |
Chaikin Money Flow: | 625350 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (51.87 - 55.13) | Sell |
Bollinger Bands (100): | (52.82 - 56.94) | Sell |
NRBO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.68 | Sell |
20-day SMA: | 2.71 | Sell |
50-day SMA: | 3.09 | Sell |
200-day SMA: | 3.94 | Sell |
8-day EMA: | 2.65 | Sell |
20-day EMA: | 2.76 | Sell |
50-day EMA: | 3.06 | Sell |
200-day EMA: | 5 | Sell |
CYTK Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 51.67 | Buy |
20-day SMA: | 53.22 | Sell |
50-day SMA: | 54.14 | Sell |
200-day SMA: | 61.3 | Sell |
8-day EMA: | 52.06 | Buy |
20-day EMA: | 52.83 | Sell |
50-day EMA: | 53.92 | Sell |
200-day EMA: | 55.59 | Sell |
NeuroBo Pharmaceuticals Earnings Growth & NRBO Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Cytokinetics Earnings Growth & CYTK Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.28 per share, and an increase next year of $0.22 per share.
NeuroBo Pharmaceuticals Technical Analysis
Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Cytokinetics Technical Analysis
Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |